drugset / Trial / NCT05324904
Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate and compare the efficacy and safety of intralesional acyclovir versus intralesional vitamin D3 in the treatment of plantar warts
Timeline
- Start
- 2022-10
- Primary completion
- 2023-10
- Completion
- 2023-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acyclovir | Small molecule | 250 mg | Other |
| Comparator | Cholecalciferol | Other / unclassified | 60000 iu | Other |